Targeting DNA polymerase ß for therapeutic intervention.

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry
• Cancer Research

Background:

• DNA damage is a key factor in diseases like cancer, diabetes, and neurodegeneration.
• DNA repair proteins maintain genome integrity, potentially reducing disease onset.
• DNA polymerase ß (Polß) is central to base excision repair and involved in genome maintenance, oncogenic transformation, and cellular responses to stress and genotoxicants.

Purpose of the Study:

• To explore the therapeutic potential of DNA polymerase ß (Polß) inhibitors in cancer treatment.
• To address the challenges in developing specific Polß inhibitors due to its complex regulatory roles.
• To review existing small molecule inhibitors and discuss novel inhibition strategies for Polß.

Main Methods:

• Summary of reported small molecule inhibitors of Polß.
• Discussion of genetic, biochemical, and chemical studies relevant to Polß inhibition.
• Exploration of potential inhibitor combinatorial approaches and tumor specificity.

Main Results:

• Polß's multifaceted role in DNA metabolism complicates the development of targeted inhibitors.
• Multiple enzymatic activities, binding partners, and post-translational modifications offer various inhibition opportunities.
• Existing research highlights diverse approaches to targeting Polß for therapeutic intervention.

Conclusions:

• Polß inhibitors show promise for improving chemotherapy and radiation response in cancer.
• Overcoming Polß's complex regulation is key to developing effective and safe inhibitors.
• Further research into combinatorial strategies and tumor-specific targeting is warranted for successful therapeutic application.